Blood heregulin and its relation with efficacy of EGFR-tyrosine kinase inhibitor in EGFR-mutant non-small cell lung cancer
Not Applicable
- Conditions
- EGFR-mutant NSCLC
- Registration Number
- JPRN-UMIN000035119
- Lead Sponsor
- Kindai University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the relation of blood heregulin level with the responsiveness of EGFR-TKI
- Secondary Outcome Measures
Name Time Method